Developer docs
API playgroundTry for free, no card

Search company profiles

Biofuture

Full company profile

uuid002ixjs

Namestring
Biofuture
Legal namestring
Demy-Colton Inc.
Websiteurl
biofuture.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

BioFuture is an annual biopharma and healthcare technology conference produced by Demy-Colton Inc. and held at Cure (345 Park Avenue South, New York City). The event convenes 500+ global attendees, 100+ speakers, and 50+ presenting companies across therapeutic areas including oncology, CNS/neurological disorders, immuno-oncology, autoimmune disease, longevity, and AI-driven drug discovery. Programming is structured around three core components: hour-long Spotlight Panel Discussions featuring 5 presenting companies per panel, a Seed Showcase for sub-$2M-funded startups with live pitch-doctor feedback, and one-to-one partnering meetings scheduled through the third-party Hello Partnering platform (EBD Group).

The business generates revenue through four streams: tiered presenting-company registration fees ($950–$2,500 per company), four-tier sponsorship packages (Diamond/Platinum/Gold/Silver) plus à la carte add-ons (lanyards, Wi-Fi branding, breakout rooms, exhibit space, sponsored email to a 33,000-contact database), on-floor exhibiting fees, and database/email monetization. Go-to-market is event-driven: company presentation slots and sponsorships are sold direct by Demy-Colton's business development team (Chief Business Officer Lila Taylor, Director Linda Burke), while investor and attendee registration is self-serve through the BioFuture website. Marketing relies on founding-board networks (Stifel, Aisling Capital, Pappas Capital, Scientific American, KKH Advisors), media partnerships (STAT News, BioWorld, GEN, Big4Bio, Scientific American), and direct outreach to Demy-Colton's curated life sciences database.

The company is privately held under Demy-Colton Inc., founded and led by Sara Jane Demy, with no disclosed funding rounds, no public ticker, and no parent-company ownership. The 2026 edition is scheduled for October 27–28 in New York City with a virtual partnering week November 3–5, indicating a hybrid format expansion. The addressable customer base spans biotech and biopharma companies (private and public), institutional and angel investors, pharma and healthcare executives, early-stage seed startups, and TechBio/digital-health ventures.

Short descriptiontext

BioFuture is an annual New York City conference produced by Demy-Colton Inc. that brings together 500+ biopharma and TechBio companies, investors, and industry leaders for Spotlight Panels, Seed Showcases, and one-to-one partnering meetings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biopharma conference, healthcare innovation events, investor partnering meetings, life sciences networking, seed showcase pitching
Industry3 codes
PRIMARYTHAHAJAA
Medical & Health Sciences Congresses
SECONDARYTHAHAJAB
Life Sciences & Biotechnology Congresses
SECONDARYMPAGAGAF
Healthcare & Medical Congresses
NAICS code2 codes
  • Religious, Grantmaking, Civic, Professional, and Similar Organizations813
  • Business Associations813910
Product category
Biopharma Conference and Events
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Company Presentation Fees
TypeOne Time License
Description

BioFuture charges registration fees for companies presenting at the conference. Seed companies pay $950-$1,150; private and public companies pay $2,200-$2,500 depending on timing. Additional employees pay $500 each.

biofuture.com
2Sponsorship Packages
TypeOne Time License
Description

Tiered sponsorship opportunities at Diamond, Platinum, Gold, and Silver levels with benefits including speaking opportunities, program development input, registrations, logo placement on signage and materials, and flexible add-ons such as partnering system, lanyards, exhibit space, breakout rooms, sponsored emails, and Wi-Fi branding.

biofuture.com
3Exhibiting Fees
TypeOne Time License
Description

Flexible exhibit space on the main conference floor available for purchase; companies can reserve space to showcase their products and engage with attendees.

biofuture.com
4Sponsored Email to Database
TypeAdvertising
Description

Sponsors can purchase sponsored email placements to Demy-Colton's 33,000-person database, providing targeted marketing exposure to a curated life sciences audience.

biofuture.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details8 tiers
1Seed Company Registration
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

$950 Early Bird (ends July 31) | $1,050 Regular (ends October 26) | $1,150 On-Site. Includes one presenter. Eligibility: Under $2M total funding, less than 3 years old, fewer than 5 employees.

biofuture.com
2Private Company Registration
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

$2,200 Early Bird (ends July 31) | $2,350 Regular (ends October 26) | $2,500 On-Site. Includes one presenter. Additional employees: $500 each. Must be seeking A-round or later funding.

biofuture.com
3Public Company Registration
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

$2,200 Early Bird (ends July 31) | $2,350 Regular (ends October 26). Mid-, small- and micro-cap public companies invited.

biofuture.com
4Diamond Sponsorship
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Includes speaking opportunity (panel), program development contribution, 5 registrations, logo on signage, recognition on printed materials/website.

biofuture.com
5Platinum Sponsorship
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Includes speaking opportunity (panel), program development contribution, 3 registrations, logo on signage, recognition on printed materials/website.

biofuture.com
6Gold Sponsorship
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Includes speaking opportunity (panel), 2 registrations, logo on signage, recognition on printed materials/website.

biofuture.com
7Silver Sponsorship
ModelOne time/ perpetual licenseBilling cadenceOne time/ perpetual license
Notes

Includes 1 registration, logo on signage, recognition on printed materials/website.

biofuture.com
8Additional Add-on Sponsorship Options
ModelOtherBilling cadenceOne time/ perpetual license
Notes

Partnering System, Lanyard, Online and Onsite Banner Logo Branding, Water Bottles, Exhibit Space Available, Sponsored Email to Demy-Colton Database (33,000 contacts), Breakout Room, Company Showcase, Company Logo in Marketing Email, Wi-Fi. Custom packages also available.

biofuture.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Biofuture is an annual in-person healthcare innovation conference held in New York City that convenes biopharma companies, investors, pharma executives, and TechBio startups for spotlight panel presentations, seed showcases, and one-to-one partnering meetings. The event enables structured deal-making through the Hello Partnering platform and offers tiered sponsorship and registration opportunities for biotech, AI-driven drug discovery, and digital health organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 500+ global attendees per edition
+4 more records
Product overview1 text field

BioFuture is an annual in-person conference event held in New York City at Cure (345 Park Avenue South) that serves as a platform for the biopharma, digital health, and life sciences ecosystem. The event features three main components: (1) Spotlight Panel Discussions - hour-long curated sessions where 5 selected companies present their innovations followed by interactive panel dialogue; (2) Seed Showcase - a dedicated track for early-stage companies to pitch with expert feedback; and (3) Hello Partnering Platform - an online scheduling system enabling one-to-one meetings between attendees. The conference attracts 500+ global attendees, 50+ presenting companies, and 100+ speakers across therapeutic areas including oncology, CNS/neurological, AI drug discovery, longevity, and immunology.

Product and service4 records
1BioFuture Annual Conference
CategoryBiopharma Conference and Events
Description

Annual in-person healthcare and biopharma conference held in New York City that brings together innovators, investors, and industry leaders to discuss the future of biopharma, digital medicine, AI, and healthcare technology. Attracts 500+ global attendees, 50+ presenting companies, and 100+ speakers per edition.

2Spotlight Panel Discussions
CategoryConference Programming
Description

Hour-long interactive panel discussions featuring 5 selected companies delivering 5-minute introductions followed by moderator-led group dialogue and audience Q&A, organized by therapeutic focus areas such as cancer therapeutics, CNS health, AI drug discovery, and longevity.

3Seed Showcase
CategoryConference Programming
Description

High-visibility platform for early-stage life sciences startups (under $2M funding, less than 3 years old, fewer than 5 employees) to deliver 5-minute company presentations and receive real-time feedback from investor and industry Pitch Doctors.

4Hello Partnering Platform (BioFuture Edition)
CategoryPartnering Technology
Description

Online partnering system enabling one-to-one meetings between attendees, investors, and presenting companies, with options for virtual meetings and pre-recorded company presentations for on-demand viewing. Supports both in-person meetings during the conference and a virtual partnering week after the event.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierCoreTypeGTM or Marketing Partner
Description

EY is a founding sponsor and sits on the BioFuture founding board through Tim Opler (Managing Director). EY provides strategic insights, reputation, and relationships to the conference ecosystem and is a Gold-level sponsor of BioFuture 2026.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Jeremy A. Abbate, VP & Publisher of Scientific American, is on the BioFuture founding board. Scientific American is a founding media partner providing brand credibility and media amplification for the conference.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Kimberly Ha, CEO & Founder of KKH Advisors, is on the BioFuture founding board. KKH Advisors provides strategic guidance on the intersection of biopharma and digital/tech evolution and contributes to program content development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cure is the venue partner and headquarters for BioFuture. Located at 345 Park Avenue South, NYC, Cure is a premier healthcare innovation ecosystem providing knowledge, infrastructure, and tools to accelerate progress toward cures. The campus houses flagship event venues and is home to healthcare organizations from idea stage to public companies.

5Hello Partnering (EBD Group)
Strategic tierCoreTypeTechnology or Integration
Description

Hello Partnering is the partnering platform used by BioFuture to enable one-to-one meeting scheduling between attendees, investors, and presenting companies. The platform supports both in-person meetings during the conference and virtual partnering weeks after the event.

biofuture.com
6Hotel AKA Nomad
Strategic tierMinorTypeOthers
Description

Hotel AKA Nomad is BioFuture's preferred hotel for attendees. Located at 31st Street and Madison Avenue, it is a five-minute walk to Cure and offers both hotel accommodations and furnished residences with business, wellness, and lifestyle amenities.

biofuture.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Regeneron is a past sponsor and supporter of BioFuture. Nouhad Husseini, Senior VP BD & Corporate Strategy at Regeneron, has participated as a speaker. Regeneron's sponsorship and speaker participation signal pharma industry endorsement of the conference.

Strategic tierMinorTypeGTM or Marketing Partner
Description

STAT News is a media partner for BioFuture, providing editorial coverage and amplifying event announcements, speaker lineups, and key discussions to its healthcare-focused readership.

Strategic tierMinorTypeGTM or Marketing Partner
Description

BioWorld is a media partner for BioFuture, helping amplify conference content and announcements to its audience of life sciences industry professionals and investors.

10Demy-Colton
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Demy-Colton is the conference organizer and producer of BioFuture. Led by Sara Jane Demy (CEO & Founder) and a professional staff team, Demy-Colton manages all aspects of conference production, partnering platform operation, sponsorship sales, and program development.

biofuture.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Patrik Frei, CEO of Venture Valuation, manages the partnering function at BioFuture. Venture Valuation provides partnering coordination and business development support for the conference's one-to-one meeting program.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Thermo Fisher Scientific (PPD) is listed as a past sponsor, supporting BioFuture's mission to connect the life sciences community.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Hogan Lovells is listed as a past sponsor and supporter of BioFuture. The law firm provides legal and regulatory expertise, and its professionals (including Alice Valder Curran) participate as speakers. Their endorsement signals regulatory and compliance community support for the conference.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Charles River Laboratories is listed as a past sponsor and speaker contributor at BioFuture. Julie Frearson, SVP & CSO at Charles River Laboratories, participates as a speaker, providing drug discovery and development expertise to the program.

Strategic tierMinorTypeOthers
Description

NYC Health + Hospitals (Jacobi/NCB) is a registered attendee and participant at BioFuture. Komal Bajaj, Chief Quality Officer, serves on panels discussing longevity therapeutics and health equity.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

A large events and media group whose life-sciences portfolio (e.g., CPHI, BIO-Europe partners, festivals including Citeline events) competes with BioFuture for sponsor budgets and producing-company attention at much larger scale.

TypeBroad incumbent
Description

The largest annual healthcare investor conference, held every January in San Francisco. It is the dominant deal-making forum BioFuture explicitly competes with for the same biotech/investor audience, but at vastly larger scale (~10,000+ attendees).

TypeBroad incumbent
Description

An investment-bank-hosted annual healthcare/life-sciences conference presenting public and private biotechs to institutional investors. Mirrors BioFuture's investor-conference positioning but operates at greater scale and brand.

4BIO International Convention
TypeBroad incumbent
Description

BIO's flagship annual convention brings together the global biotech industry for partnering, programming and exhibition. It targets the same biopharma executives, investors and presenting companies as BioFuture, with substantially broader international attendance.

5Biotech Showcase (EBD Group)
TypeDirect peer
Description

An investor and partnering conference held annually in San Francisco alongside J.P. Morgan, featuring presenting biotech companies and one-to-one meetings through the partneringONE platform. Closest direct analogue to BioFuture's investor-facing, presentation-driven format.

TypeDirect peer
Description

A Europe-based partnering conference organized by the Biotechnology Innovation Organization, focused on one-to-one meetings between biotechs and pharma/investors via EBD Group's partneringONE platform — directly analogous to BioFuture's Hello Partnering model.

7RESI Conference (Life Science Nation)
TypeDirect peer
Description

Redefining Early Stage Investments is an early-stage life-sciences investor conference with partnering and pitch formats targeting seed and Series A biotechs — the same presenting-company segment as BioFuture's Seed Showcase.

8BIO CEO & Investor Conference
TypeDirect peer
Description

Annual conference focused on publicly traded biotech companies and institutional investors, with company presentations and one-on-one partnering. Competes with BioFuture for the public-company-presentation audience.

TypeRegional player
Description

BIO's Asia-Pacific biotech partnering conference. Same model (presentations + partnering + investor focus) but in Asia, where BioFuture does not currently compete and where it could expand if pursuing geographic growth.

TypeDirect peer
Description

BioCentury produces proprietary investor events such as the BioCentury Grand Rounds and Back to School sessions, plus the BCIQ Summit, targeting the same biotech/investor audience as BioFuture but with a heavier editorial/content focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biofuture

Biopharma Conference and Eventsbiofuture.com

BioFuture is an annual New York City conference produced by Demy-Colton Inc. that brings together 500+ biopharma and TechBio companies, investors, and industry leaders for Spotlight Panels, Seed Showcases, and one-to-one partnering meetings.

What Biofuture does

BioFuture is an annual biopharma and healthcare technology conference produced by Demy-Colton Inc. and held at Cure (345 Park Avenue South, New York City). The event convenes 500+ global attendees, 100+ speakers, and 50+ presenting companies across therapeutic areas including oncology, CNS/neurological disorders, immuno-oncology, autoimmune disease, longevity, and AI-driven drug discovery. Programming is structured around three core components: hour-long Spotlight Panel Discussions featuring 5 presenting companies per panel, a Seed Showcase for sub-$2M-funded startups with live pitch-doctor feedback, and one-to-one partnering meetings scheduled through the third-party Hello Partnering platform (EBD Group).

The business generates revenue through four streams: tiered presenting-company registration fees ($950–$2,500 per company), four-tier sponsorship packages (Diamond/Platinum/Gold/Silver) plus à la carte add-ons (lanyards, Wi-Fi branding, breakout rooms, exhibit space, sponsored email to a 33,000-contact database), on-floor exhibiting fees, and database/email monetization. Go-to-market is event-driven: company presentation slots and sponsorships are sold direct by Demy-Colton's business development team (Chief Business Officer Lila Taylor, Director Linda Burke), while investor and attendee registration is self-serve through the BioFuture website. Marketing relies on founding-board networks (Stifel, Aisling Capital, Pappas Capital, Scientific American, KKH Advisors), media partnerships (STAT News, BioWorld, GEN, Big4Bio, Scientific American), and direct outreach to Demy-Colton's curated life sciences database.

The company is privately held under Demy-Colton Inc., founded and led by Sara Jane Demy, with no disclosed funding rounds, no public ticker, and no parent-company ownership. The 2026 edition is scheduled for October 27–28 in New York City with a virtual partnering week November 3–5, indicating a hybrid format expansion. The addressable customer base spans biotech and biopharma companies (private and public), institutional and angel investors, pharma and healthcare executives, early-stage seed startups, and TechBio/digital-health ventures.

Biofuture firmographics

Firmographics
Name
Biofuture
Legal name
Demy-Colton Inc.
Website
https://biofuture.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
251–500 employees
Short description
BioFuture is an annual New York City conference produced by Demy-Colton Inc. that brings together 500+ biopharma and TechBio companies, investors, and industry leaders for Spotlight Panels, Seed Showcases, and one-to-one partnering meetings.
Ownership category
akta.pro rank

Biofuture industry classification

Industry
Product category
Biopharma Conference and Events
NAICS
Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Business Associations (813910)
akta.pro industry
PRIMARYTHAHAJAA
Medical & Health Sciences Congresses
SECONDARYTHAHAJAB
Life Sciences & Biotechnology Congresses
SECONDARYMPAGAGAF
Healthcare & Medical Congresses

Keywords

  • Biopharma conference
  • Healthcare innovation events
  • Investor partnering meetings
  • Life sciences networking
  • Seed showcase pitching

Where Biofuture is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Biofuture business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Company Presentation Fees: BioFuture charges registration fees for companies presenting at the conference. Seed companies pay $950-$1,150; private and public companies pay $2,200-$2,500 depending on timing. Additional employees pay $500 each.
  2. Sponsorship Packages: Tiered sponsorship opportunities at Diamond, Platinum, Gold, and Silver levels with benefits including speaking opportunities, program development input, registrations, logo placement on signage and materials, and flexible add-ons such as partnering system, lanyards, exhibit space, breakout rooms, sponsored emails, and Wi-Fi branding.
  3. Exhibiting Fees: Flexible exhibit space on the main conference floor available for purchase; companies can reserve space to showcase their products and engage with attendees.
  4. Sponsored Email to Database: Sponsors can purchase sponsored email placements to Demy-Colton's 33,000-person database, providing targeted marketing exposure to a curated life sciences audience.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseOne time/ perpetual licenseSeed Company Registration
One time/ perpetual licenseOne time/ perpetual licensePrivate Company Registration
One time/ perpetual licenseOne time/ perpetual licensePublic Company Registration
One time/ perpetual licenseOne time/ perpetual licenseDiamond Sponsorship
One time/ perpetual licenseOne time/ perpetual licensePlatinum Sponsorship
One time/ perpetual licenseOne time/ perpetual licenseGold Sponsorship
One time/ perpetual licenseOne time/ perpetual licenseSilver Sponsorship
OtherOne time/ perpetual licenseAdditional Add-on Sponsorship Options

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Biofuture product offering

Product offering

Core offering

Biofuture is an annual in-person healthcare innovation conference held in New York City that convenes biopharma companies, investors, pharma executives, and TechBio startups for spotlight panel presentations, seed showcases, and one-to-one partnering meetings. The event enables structured deal-making through the Hello Partnering platform and offers tiered sponsorship and registration opportunities for biotech, AI-driven drug discovery, and digital health organizations.

Product overview

BioFuture is an annual in-person conference event held in New York City at Cure (345 Park Avenue South) that serves as a platform for the biopharma, digital health, and life sciences ecosystem. The event features three main components: (1) Spotlight Panel Discussions - hour-long curated sessions where 5 selected companies present their innovations followed by interactive panel dialogue; (2) Seed Showcase - a dedicated track for early-stage companies to pitch with expert feedback; and (3) Hello Partnering Platform - an online scheduling system enabling one-to-one meetings between attendees. The conference attracts 500+ global attendees, 50+ presenting companies, and 100+ speakers across therapeutic areas including oncology, CNS/neurological, AI drug discovery, longevity, and immunology.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioFuture Annual Conference Annual in-person healthcare and biopharma conference held in New York City that brings together innovators, investors, and industry leaders to discuss the future of biopharma, digital medicine, AI, and healthcare technology. Attracts 500+ global attendees, 50+ presenting companies, and 100+ speakers per edition.
  • Spotlight Panel Discussions Hour-long interactive panel discussions featuring 5 selected companies delivering 5-minute introductions followed by moderator-led group dialogue and audience Q&A, organized by therapeutic focus areas such as cancer therapeutics, CNS health, AI drug discovery, and longevity.
  • Seed Showcase High-visibility platform for early-stage life sciences startups (under $2M funding, less than 3 years old, fewer than 5 employees) to deliver 5-minute company presentations and receive real-time feedback from investor and industry Pitch Doctors.
  • Hello Partnering Platform (BioFuture Edition) Online partnering system enabling one-to-one meetings between attendees, investors, and presenting companies, with options for virtual meetings and pre-recorded company presentations for on-demand viewing. Supports both in-person meetings during the conference and a virtual partnering week after the event.

Quantifiable outcome

  • 500+ global attendees per edition
  • +4 more outcomes

Companies that use Biofuture

Customer profile

Named customers11 records

Segments5 records

Ideal customer profiles4 records

Biofuture technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Biofuture partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and minor.

  • Ernst & Young LLP (EY)coreGTM or Marketing PartnerEY is a founding sponsor and sits on the BioFuture founding board through Tim Opler (Managing Director). EY provides strategic insights, reputation, and relationships to the conference ecosystem and is a Gold-level sponsor of BioFuture 2026.
  • Scientific AmericancoreGTM or Marketing PartnerJeremy A. Abbate, VP & Publisher of Scientific American, is on the BioFuture founding board. Scientific American is a founding media partner providing brand credibility and media amplification for the conference.
  • KKH AdvisorscoreStrategic or Co-development PartnerKimberly Ha, CEO & Founder of KKH Advisors, is on the BioFuture founding board. KKH Advisors provides strategic guidance on the intersection of biopharma and digital/tech evolution and contributes to program content development.
  • Cure (Healthcare Innovation Ecosystem)coreStrategic or Co-development PartnerCure is the venue partner and headquarters for BioFuture. Located at 345 Park Avenue South, NYC, Cure is a premier healthcare innovation ecosystem providing knowledge, infrastructure, and tools to accelerate progress toward cures. The campus houses flagship event venues and is home to healthcare organizations from idea stage to public companies.
  • Hello Partnering (EBD Group)coreTechnology or IntegrationHello Partnering is the partnering platform used by BioFuture to enable one-to-one meeting scheduling between attendees, investors, and presenting companies. The platform supports both in-person meetings during the conference and virtual partnering weeks after the event.
  • Hotel AKA NomadminorOthersHotel AKA Nomad is BioFuture's preferred hotel for attendees. Located at 31st Street and Madison Avenue, it is a five-minute walk to Cure and offers both hotel accommodations and furnished residences with business, wellness, and lifestyle amenities.
  • Regeneron PharmaceuticalsminorGTM or Marketing PartnerRegeneron is a past sponsor and supporter of BioFuture. Nouhad Husseini, Senior VP BD & Corporate Strategy at Regeneron, has participated as a speaker. Regeneron's sponsorship and speaker participation signal pharma industry endorsement of the conference.
  • STAT NewsminorGTM or Marketing PartnerSTAT News is a media partner for BioFuture, providing editorial coverage and amplifying event announcements, speaker lineups, and key discussions to its healthcare-focused readership.
  • BioWorldminorGTM or Marketing PartnerBioWorld is a media partner for BioFuture, helping amplify conference content and announcements to its audience of life sciences industry professionals and investors.
  • Demy-ColtoncoreImplementation/ SI/ Consulting PartnerDemy-Colton is the conference organizer and producer of BioFuture. Led by Sara Jane Demy (CEO & Founder) and a professional staff team, Demy-Colton manages all aspects of conference production, partnering platform operation, sponsorship sales, and program development.
  • Venture Valuation / Patrik FreiminorImplementation/ SI/ Consulting PartnerPatrik Frei, CEO of Venture Valuation, manages the partnering function at BioFuture. Venture Valuation provides partnering coordination and business development support for the conference's one-to-one meeting program.
  • Thermo Fisher ScientificminorGTM or Marketing PartnerThermo Fisher Scientific (PPD) is listed as a past sponsor, supporting BioFuture's mission to connect the life sciences community.
  • Hogan LovellsminorImplementation/ SI/ Consulting PartnerHogan Lovells is listed as a past sponsor and supporter of BioFuture. The law firm provides legal and regulatory expertise, and its professionals (including Alice Valder Curran) participate as speakers. Their endorsement signals regulatory and compliance community support for the conference.
  • Charles River LaboratoriesminorGTM or Marketing PartnerCharles River Laboratories is listed as a past sponsor and speaker contributor at BioFuture. Julie Frearson, SVP & CSO at Charles River Laboratories, participates as a speaker, providing drug discovery and development expertise to the program.
  • NYC Health + Hospitals / JacobiminorOthersNYC Health + Hospitals (Jacobi/NCB) is a registered attendee and participant at BioFuture. Komal Bajaj, Chief Quality Officer, serves on panels discussing longevity therapeutics and health equity.

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Biofuture competitors and assessment

Company assessment

Broad incumbents

  • Informa (Life Sciences portfolio): A large events and media group whose life-sciences portfolio (e.g., CPHI, BIO-Europe partners, festivals including Citeline events) competes with BioFuture for sponsor budgets and producing-company attention at much larger scale.
  • J.P. Morgan Healthcare Conference: The largest annual healthcare investor conference, held every January in San Francisco. It is the dominant deal-making forum BioFuture explicitly competes with for the same biotech/investor audience, but at vastly larger scale (~10,000+ attendees).
  • Jefferies Healthcare Conference: An investment-bank-hosted annual healthcare/life-sciences conference presenting public and private biotechs to institutional investors. Mirrors BioFuture's investor-conference positioning but operates at greater scale and brand.
  • BIO International Convention: BIO's flagship annual convention brings together the global biotech industry for partnering, programming and exhibition. It targets the same biopharma executives, investors and presenting companies as BioFuture, with substantially broader international attendance.

Direct peers

  • Biotech Showcase (EBD Group): An investor and partnering conference held annually in San Francisco alongside J.P. Morgan, featuring presenting biotech companies and one-to-one meetings through the partneringONE platform. Closest direct analogue to BioFuture's investor-facing, presentation-driven format.
  • BIO-Europe: A Europe-based partnering conference organized by the Biotechnology Innovation Organization, focused on one-to-one meetings between biotechs and pharma/investors via EBD Group's partneringONE platform — directly analogous to BioFuture's Hello Partnering model.
  • RESI Conference (Life Science Nation): Redefining Early Stage Investments is an early-stage life-sciences investor conference with partnering and pitch formats targeting seed and Series A biotechs — the same presenting-company segment as BioFuture's Seed Showcase.
  • BIO CEO & Investor Conference: Annual conference focused on publicly traded biotech companies and institutional investors, with company presentations and one-on-one partnering. Competes with BioFuture for the public-company-presentation audience.
  • BioCentury (events arm): BioCentury produces proprietary investor events such as the BioCentury Grand Rounds and Back to School sessions, plus the BCIQ Summit, targeting the same biotech/investor audience as BioFuture but with a heavier editorial/content focus.

Regional players

  • BIO Asia: BIO's Asia-Pacific biotech partnering conference. Same model (presentations + partnering + investor focus) but in Asia, where BioFuture does not currently compete and where it could expand if pursuing geographic growth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Biofuture social profiles

Digital presence

Biofuture financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biofuture leadership team

Management profile

Number of profiles

Profiles10 records

Biofuture funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biofuture M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biofuture

What does Biofuture do?

Biofuture is an annual in-person healthcare innovation conference held in New York City that convenes biopharma companies, investors, pharma executives, and TechBio startups for spotlight panel presentations, seed showcases, and one-to-one partnering meetings. The event enables structured deal-making through the Hello Partnering platform and offers tiered sponsorship and registration opportunities for biotech, AI-driven drug discovery, and digital health organizations.

Is Biofuture a public or private company?

Biofuture is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biofuture founded?

Biofuture was founded in 2021. It employs 251 to 500 people.

Where is Biofuture based?

Biofuture is headquartered in New York, United States, in the North America region.

How does Biofuture make money?

Four revenue lines are on record. Company Presentation Fees are the primary driver. The others are sponsorship Packages, exhibiting Fees and sponsored Email to Database.

Who are Biofuture's main competitors?

Broad incumbents on record are Informa (Life Sciences portfolio), J.P. Morgan Healthcare Conference, Jefferies Healthcare Conference and BIO International Convention. Direct peers are Biotech Showcase (EBD Group), BIO-Europe, RESI Conference (Life Science Nation), BIO CEO & Investor Conference and BioCentury (events arm). BIO Asia is listed as a regional player.

Does Biofuture have an API?

No public API is recorded for Biofuture.

What industry is Biofuture in?

Biofuture's product category is Biopharma Conference and Events. Its primary akta.pro industry code is THAHAJAA, Medical & Health Sciences Congresses, with a secondary code of THAHAJAB, Life Sciences & Biotechnology Congresses. Its NAICS code is 813.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals